HR 340
The HCT/P Modernization Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 6:52 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The HCT/P Modernization Act of 2025 aims to improve the regulation of human cell and tissue products (HCT/Ps) by requiring the FDA to provide more information to stakeholders and conduct workshops to foster discussion and scientific advancement. The bill directs the FDA to publish educational materials, track manufacturing inspections, and report on inquiries to the Tissue Reference Group. It also establishes a public docket for feedback and requires the FDA to submit a report to Congress with recommendations for modernizing HCT/P regulations, considering factors like regulatory burden and public health.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.